Key Market Overview:
Melatonin market size was valued at USD 1.5 Billion in 2021, registering a CAGR of 14.79% during the forecast period (2022-2030), and the market is projected to be worth USD 5.1 Billion by 2030.
Melatonin or N-acetyl-5-methoxytryptamine is a hormone produced by the pineal gland in the brain that helps regulate the body’s circadian rhythm, which controls the sleep-wake cycle. Melatonin is often referred to as the “sleep hormone that is available as a dietary supplement and commonly used as a natural remedy to help with sleep issues, such as insomnia and jet lag. The melatonin market is majorly driven by increasing awareness about sleep and sleep disorders. With the growing recognition of the importance of sleep for overall health and well-being, more people are seeking natural remedies to help with sleep issues, including insomnia and jet lag. This has led to an increase in demand for melatonin supplements.
Furthermore, North America is the largest market for melatonin due to the high awareness of the importance of sleep, the presence of a large number of sleep disorder clinics, and the high consumption of sleep aids.
The increasing prevalence of sleep disorders is driving growth in the melatonin market. Sleep disorders, such as insomnia and sleep apnea, are becoming more common due to factors such as stress, unhealthy lifestyle habits, and the use of electronic devices before bedtime. This has created a larger market for sleep aids, including melatonin supplements. Additionally, the growing demand for natural sleep aids is another key driver of the melatonin market. Consumers are increasingly seeking out natural remedies that are free of side effects and drug interactions, making melatonin a popular choice.
The market for sleep aids is highly competitive, and melatonin faces competition from other natural and prescription sleep aids, which limits the growth of the melatonin market. In addition, synthetic melatonin is expensive to produce, and this high cost of production impacts the market’s overall growth. Moreover, the use of over-the-counter melatonin places teenagers and children at risk for intentional overdose.
According to the national library of medicine, melatonin has broad antioxidant and radical scavenger properties that may act as a protective agent against damage caused by UV rays. These melatonin protective effects against UV-induced damage have strong experimental support from in vitro studies. Hence the use of melatonin in skin care and cosmetics would offer lucrative opportunities in the melatonin market.
Melatonin Report Coverage:
|Report Attributes||Report Details|
|Market Size in 2030 (USD Billion)||5.1 Billion|
|By Type||Natural and Synthetic|
|By Form||Capsules & Tablets, Gummies, Liquid, and Others|
|By Application||Dietary Supplements, Medical Industry, and Others|
|By Geography||North America, Europe
Asia Pacific, Latin America and Middle East, and Africa
|Key Players||Pfizer Inc., GlaxoSmithKline plc., Bio-Tech Pharmacal, Inc., Merck KGaA, Aspen Pharmacare Holdings, Ralington Pharma, The Dow Chemical Company, BioTech Corporation , and Natrol.|
The Type segment is bifurcated into natural and synthetic. The natural melatonin segment dominated the melatonin market attributed to the growing demand for natural and non-pharmacological options for improving sleep quality. Additionally, the increasing awareness about the potential side effects of synthetic melatonin is also expected to drive the demand for natural melatonin.
The synthetic melatonin segment is expected to register the fastest growth in terms of CAGR during the forecast period. Synthetic melatonin is a chemically manufactured form of the hormone and is used in pharmaceutical products for the treatment of sleep disorders. Synthetic melatonin is a more potent form of melatonin and is commonly used to treat sleep disorders, such as insomnia.
The Form segment is classified into capsules & tablets, gummies, liquid, and others. The capsule & tablets segment holds the largest share in terms of revenue to the market growth. The factors such as wide availability and ease of consumption make them a popular choice among consumers. Capsules and tablets come in various strengths, and they are purchased over the counter without a prescription. They are a convenient form of melatonin for people who are looking for an easy and discreet way to take their supplements.
Furthermore, gummies form is anticipated to grow at a steady rate in terms of CAGR attributed to the fact that the gummies have gained popularity among consumers due to their pleasant taste and ease of consumption. Gummies are available in various fruit flavors, and they are easily chewed or sucked like candy. Additionally, gummies offer a convenient and discreet way to take melatonin, making them a popular choice for people who are on-the-go.
The Application segment is divided into dietary supplements, the medical industry, and others. The medical industry contributes the largest share to the industry’s growth in terms of value. The medical industry is a key segment in the melatonin market, where it is used as a treatment for various sleep disorders, including insomnia and jet lag. In this industry, melatonin is prescribed by healthcare professionals and is often available in various forms, including tablets, capsules, and liquids. The medical use of melatonin is backed by scientific research, and it is considered a safe and effective treatment for sleep disorders. Melatonin is commonly used in hospitals, sleep clinics, and other healthcare facilities, and its popularity as a sleep aid continues to grow. The medical industry is also driving the development of new and improved forms of melatonin, as well as research into new applications for this versatile hormone
Moreover, dietary supplements are projected to grow at a substantial rate in terms of CAGR. Attributed to the fact that melatonin dietary supplements are designed to help people who have trouble sleeping, and they are often taken before bedtime. These supplements are available in various forms, including tablets, capsules, liquids, and gummies, and they come in various strengths. The popularity of melatonin dietary supplements stems from their reputation as a natural and safe alternative to traditional sleep aids, such as prescription medications.
The regional segment includes Asia Pacific, Europe, North America, the Middle East, and Africa, Latin America. Europe contributes the largest share in terms of revenue to the market growth. The market for melatonin is driven by factors such as the growing awareness about the benefits of melatonin for sleep and its increasing use in dietary supplements and cosmetics Types. Additionally, the high incidence of sleep disorders and the aging population in Europe is also expected to drive the growth of the melatonin market in the region.
Furthermore, Asia pacific is anticipated to substantially grow in the market in the forecast period due to several factors such as the growing tourism industry in the region, as tourists seek natural and non-pharmacological options for improving sleep quality while traveling. In addition, the aging population in the region is expected to drive the demand for melatonin-based Types, as sleep quality tends to decline with age.
Melatonin Market Competitive Landscape: (make a few changes)
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. These players compete based on factors such as Type quality, price, brand image, and distribution network. To remain competitive, many companies are focusing on expanding their type portfolios, investing in research and development, and improving their distribution networks. Additionally, companies are also focusing on strategic partnerships and collaborations to enhance their market presence and increase their competitiveness. Key players are:
- Pfizer Inc.
- GlaxoSmithKline plc.
- Bio-Tech Pharmacal, Inc.
- Merck KGaA
- Aspen Pharmacare Holdings
- Ralington Pharma
- The Dow Chemical Company
- BioTech Corporation
- Pharmavite, a company known for its leadership in the health and wellness sector, has chosen IRI as its preferred partner for market and consumer insights. Pharmavite, the manufacturer of Nature Made vitamins, is one of the many firms that use IRI’s cutting-edge analytics and modeling tools to enhance brand expansion.
- In January 2021 Aurobindo Pharma, a company based in Hyderabad, India, sold Natrol LLC., which is a subsidiary of Aurobindo Pharma USA Inc., to a private equity firm called New Mountain Capital and its associate Jarrow Formulas, in a cash transaction valued at $550 million.
Table of Content
To check our Table of Contents, please mail us at: [email protected]
Research MethodologyThe Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.